113 related articles for article (PubMed ID: 26748694)
1. The influence of 5-HT(2A) activity on a 5-HT(2C) specific in vivo assay used for early identification of multiple acting SERT and 5-HT(2C) receptor ligands.
Éliás O; Nógrádi K; Domány G; Szakács Z; Kóti J; Szántay C; Tarcsay Á; Keserű GM; Gere A; Kiss B; Kurkó D; Kolok S; Némethy Z; Kapui Z; Hellinger É; Vastag M; Sághy K; Kedves R; Gyertyán I
Bioorg Med Chem Lett; 2016 Feb; 26(3):914-920. PubMed ID: 26748694
[TBL] [Abstract][Full Text] [Related]
2. Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.
Eliás O; Agai-Csongor E; Domány G; Keserű GM; Gere A; Kiss B; Hellinger E; Vastag M; Gyertyán I
Bioorg Med Chem Lett; 2014 May; 24(9):2118-22. PubMed ID: 24717153
[TBL] [Abstract][Full Text] [Related]
3. Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
Kang SY; Park EJ; Park WK; Kim HJ; Jeong D; Jung ME; Song KS; Lee SH; Seo HJ; Kim MJ; Lee M; Han HK; Son EJ; Pae AN; Kim J; Lee J
Bioorg Med Chem Lett; 2010 Mar; 20(5):1705-11. PubMed ID: 20149649
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-depressant effects of phthalazinone-based triple-acting small molecules against 5-HT
Kim J; Cha E; Park WK; Lee HY; Lim SM; Kim HJ; Pae AN
Bioorg Med Chem Lett; 2020 Feb; 30(4):126882. PubMed ID: 31889666
[TBL] [Abstract][Full Text] [Related]
5. New 5-HT
Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
[TBL] [Abstract][Full Text] [Related]
6. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins.
Bécamel C; Gavarini S; Chanrion B; Alonso G; Galéotti N; Dumuis A; Bockaert J; Marin P
J Biol Chem; 2004 May; 279(19):20257-66. PubMed ID: 14988405
[TBL] [Abstract][Full Text] [Related]
7. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
8. Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
Kang SY; Park EJ; Park WK; Kim HJ; Choi G; Jung ME; Seo HJ; Kim MJ; Pae AN; Kim J; Lee J
Bioorg Med Chem; 2010 Aug; 18(16):6156-69. PubMed ID: 20637635
[TBL] [Abstract][Full Text] [Related]
9. 5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.
Huang M; Dai J; Meltzer HY
Eur J Pharmacol; 2011 Feb; 652(1-3):40-5. PubMed ID: 21118683
[TBL] [Abstract][Full Text] [Related]
10. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
Allerton CM; Andrews MD; Blagg J; Ellis D; Evrard E; Green MP; Liu KK; McMurray G; Ralph M; Sanderson V; Ward R; Watson L
Bioorg Med Chem Lett; 2009 Oct; 19(19):5791-5. PubMed ID: 19716297
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
15. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Seo HJ; Park EJ; Kim MJ; Kang SY; Lee SH; Kim HJ; Lee KN; Jung ME; Lee M; Kim MS; Son EJ; Park WK; Kim J; Lee J
J Med Chem; 2011 Sep; 54(18):6305-18. PubMed ID: 21823597
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Zaniewska M; McCreary AC; Wydra K; Filip M
Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.
Fevig JM; Feng J; Rossi KA; Miller KJ; Wu G; Hung CP; Ung T; Malmstrom SE; Zhang G; Keim WJ; Cullen MJ; Rohrbach KW; Qu Q; Gan J; Pelleymounter MA; Robl JA
Bioorg Med Chem Lett; 2013 Jan; 23(1):330-5. PubMed ID: 23177783
[TBL] [Abstract][Full Text] [Related]
19. 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter.
Qu Y; Villacreses N; Murphy DL; Rapoport SI
Psychopharmacology (Berl); 2005 Jun; 180(1):12-20. PubMed ID: 15834538
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
